FindTrial
Sign In

The application of atosiban in patient with endometriosis and infertility undergoing IVF-ET treatment

The research of the level of oxytocin and oxytocin receptor in patient with endometriosis and infertility

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOQ-14005715
Enrollment
Unknown
Registered
2014-12-28
Start date
2014-12-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

None endometriosis uterina group:Atosiban
None endometriosis uterina group:Blank
endometriosis uterina group:Atosiban
endometriosis uterina group:Blank

Sponsors

Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. age older than 20 years; 2. basal FSH less than 10IU/L; 3. endometriosis contribute to infertility; 4. meet the transplantation condition of this cycle; 5. IVF-ET is needed to improve pregnancy due to ovarian ducts problem, or husband problem, or other reasons.

Exclusion criteria

Exclusion criteria: 1. abnomal uterine cavity; 2. myoma of uterus; 3. hydrosalpinx; 4. chromosome abnormality.

Design outcomes

Primary

MeasureTime frame
pregnancy rate;oxytocin level;Uterine contraction;PGF2a level;PP14 level;—

Countries

China

Contacts

Public ContactWei Zhaolian
weizhaolian_1@126.com+86 13865916162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 13, 2026